The nomination committee of the medtech company Redsense Medicals proposes that Michael A Kraus be elected as a new board member at the annual general meeting on May 20 in Halmstad. Kraus is described as a recognized leader in CRRT, home dialysis and ESKD care, with extensive experience in patient care, administration and government relations. He has authored numerous manuscripts and book chapters and is an internationally recognized speaker.He is said to be independent of the company, management and major shareholders.